Clinical data were collected from medical records, including name, age, gender, preoperative-neutrophil, preoperative-lymphocyte, con-lymphocyte, con-platelet, post-neutrophil, post-lymphocyte, post-platelet, tumor size, tumor site, histopathological tumor grade, dose of gross tumor volume of tumor bed, dose of Clinical Tumor volume 1, dose of Clinical Tumor volume 2, WHO grade, adjuvant treatment methods (chemo-radiotherapy, radiotherapy, chemotherapy, or only surgical resection), and cycles of adjuvant chemotherapy. The endpoints included the OS, progression-free survival (PFS). The calculated methods were as follows: SII = platelets × neutrophils/lymphocytes, NLR = neutrophils/lymphocytes, and PLR = platelets/lymphocytes.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.